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Abstract
The CREB3 subfamily of membrane-bound bZIP transcription factors has five members in mammals known as
CREB3 and CREB3L1-L4. One current model suggests that CREB3 subfamily transcription factors are similar to ATF6
in regulated intramembrane proteolysis and transcriptional activation. Particularly, they were all thought to be
proteolytically activated in response to endoplasmic reticulum (ER) stress to stimulate genes that are involved in
unfolded protein response (UPR). Although the physiological inducers of their proteolytic activation remain to be
identified, recent findings from microarray analyses, RNAi screens and gene knockouts not only demonstrated their
critical roles in regulating development, metabolism, secretion, survival and tumorigenesis, but also revealed cell
type-specific patterns in the activation of their target genes. Members of the CREB3 subfamily show differential
activity despite their structural similarity. The spectrum of their biological function expands beyond ER stress and
UPR. Further analyses are required to elucidate the mechanism of their proteolytic activation and the molecular
basis of their target recognition.
Introduction
The CREB3 subfamily of bZIP transcription factors in
mammals comprises CREB3 (also known as LZIP or
Luman), CREB3L1 (OASIS), CREB3L2 (BBF2H7),
CREB3L3 (CREB-H) and CREB3L4 (AIbZIP) [1].
CREB3, the prototype of this subfamily, was first identi-
fied through its interaction with a transcriptional coacti-
vator termed host cell factor 1 (HCF1) [2]. CREB3L1
was initially found in long-term cultured mouse astro-
cytes and thought to have a role in gliotic events [3].
CREB3L2 was identified as part of a fusion oncoprotein
named FUS-CREB3L2, which was generated by a chro-
mosomal translocation in low grade fibromyxoid sar-
coma (LGFMS) [4]. For CREB3L3, it was first reported
to be a liver-specific transcription factor [5]. CREB3L4
was originally identified as a highly expressed and
androgen-induced protein in prostate cancer cells [6].
The CREB3 subfamily members are closely-related to
Drosophila dCREB-A/BBF2 [7,8]. They share significant
homology within their bZIP domain that mediates
DNA-binding and dimerization [9]. Similar to ATF6,
they also feature a transmembrane domain at the
immediate C-terminal side of the bZIP region (Figure 1)
[1,10]. As such, they are type II membrane-associated
proteins with the N-terminus facing the cytoplasm and
the C-terminus penetrating through the endoplasmic
reticulum (ER) membrane into the ER lumen [11,12].
Based on their structural similarity to ATF6, transcrip-
tion factors of the CREB3 subfamily are thought to be
activated through regulated intramembrane proteolysis
(RIP) in response to ER stress [12]. Upon activation,
they are transported from the ER to the Golgi apparatus
and proteolytically cleaved there by site 1 protease (S1P)
and S2P sequentially to release the N-terminal fragment,
which translocates into the nucleus to activate the tran-
scription of genes that play important roles in unfolded
protein response (UPR) [12,13]. This model is generally
applicable to ATF6 and all CREB3 subfamily transcrip-
tion factors (Figure 2). In this model, the ER-anchored
uncleaved full-length form of the transcription factor
remains inactive. Activation through RIP ensures a rapid
and timely response to ER stress and UPR [1,10,14-16].
RIP is therefore a rate-limiting step in transcription fac-
tor activation. In addition to RIP, there are several other
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Figure 1 The human CREB3 subfamily of transcription factors. The bZIP domains of the members are aligned. TA: transcriptional activation
domain. bZIP: basic leucine zipper domain. TM: transmembrane domain.
Figure 2 Activation of membrane-bound transcription factors of the CREB3 subfamily. CREB3 subfamily proteins are anchored to the ER
membrane in an inactive form when they are not stimulated. Only upon stimulation, the CREB3 subfamily proteins are translocated by COPII
vesicles from the ER to the Golgi apparatus where they will encounter S1P and S2P proteases. They are cleaved to release the N-terminal
fragments which will enter the nucleus to activate transcription of target genes. CREB3 subfamily proteins might work as homodimers or
heterodimers in the nucleus to activate gene expression.
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regulatory points. For example, the N-terminal active
form of CREB3 subfamily transcription factors can form
homo- and hetero-dimers with differential transcrip-
tional activity [9]. Particularly, CREB3L3 was suggested
to form a heterodimer with ATF6 to synergistically acti-
vate target genes [17]. Whether this heterodimer is ther-
modynamically stable and functional remains to be
determined.
Although it is well accepted that the CREB3 subfamily
transcription factors are activated through RIP, the jury
is still out for several fundamentally important questions
in the model that explains their activation. First, the
physiological stimuli for proteolytic activation of discrete
transcription factors in the CREB3 subfamily remain to
be identified. Particularly, it will be of interest to clarify
whether all these transcription factors are activated by
ER stress. Second, the physiological targets of these
transcription factors should be further characterized.
Importantly, whether and how they activate UPR genes
and other targets warrant additional analyses. Finally,
the physiological roles of different transcription factors
in this subfamily merit further investigations. Specifi-
cally, it will be of pivotal importance to determine how
different factors execute their function in different tis-
sues and cells. In this minireview, we will briefly discuss
recent findings that advance our understanding in the
above three areas. Collectively, the new evidence sup-
ports the notion that the five members in this subfamily
have cell type-specific roles. Malfunction of these tran-
scription factors is implicated in different diseases
including cancer.
Physiological roles of CREB3 subfamily transcription
factors
One important insight of the CREB3 subfamily tran-
scription factors was derived from Creb3l1 and
Creb3l2 knockout mice [18]. Both CREB3L1 and
CREB3L2 were previously implicated in UPR in astro-
cytes or glioma cells. They were shown to undergo RIP
under ER stress, leading to the activation of Grp78
[15]. Although hippocampal pyramidal neurons in
Creb3L1-/- mice were slightly more susceptible to kai-
nic acid, which also induces ER stress [19], the lack of
either Grp78 reduction or strong neuronal phenotypes
in the knockout mice raised significant concerns about
the validity of the earlier data obtained from cultured
glioma cells. In addition, one recent study indicated
that expression of CREB3L1 in pancreatic b-cells did
not induce Grp78 or other classical UPR genes, but
boosted a subset of genes involved in the production
of extracellular matrix proteins [20]. Thus, further ana-
lyses or re-analyses are required to resolve the discre-
pancies in the activation of UPR genes by CREB3L1
and CREB3L2.
The new findings from mouse model indicated the
requirement of CREB3L1 for bone formation [18].
CREB3L1 was found to be abundantly expressed in
osteoblasts. In the Creb3l1 knockout mice, severe osteo-
penia was observed as the result of a drop in type 1 col-
lagen in the bone matrix together with a decrease in the
osteoblast activity. These osteoblasts were found to pos-
sess abnormally enlarged rough ER in which a large
amount of bone matrix proteins were accumulated. The
cause for this phenotype in Creb3l1-/- osteoblasts is still
unclear but it could be due to the lack of activation of
CREB3L1 target genes required for transport of bone
matrix proteins from ER to Golgi. On the other hand,
the type 1 collagen gene Col1a1 was identified as a
direct target of CREB3L1 whose transactivation is
achieved via an enhancer element in the osteoblast-spe-
cific Col1a1 promoter. CREB3L1 was essential for bone
formation, plausibly by activating Col1a1 transcription
and the secretion of bone matrix proteins [18]. This is
the first evidence in support of a role for CREB3L1 in
the secretory pathway.
Interestingly, a back-to-back paper on Creb3l2 knock-
out mice demonstrated a crucial role of CREB3L2 in
chondrogenesis [21]. Sec23a, a coat protein complex II
(COPII) component for transporting proteins from ER
to Golgi, was shown to be a target of CREB3L2. The
Creb3l2-/- mice suffered from severe chondrodysplasia
and had an immature chest cavity causing death from
suffocation within a short time after birth. There were
defects in cartilage formation and the abundance of
extracellular matrix proteins was prominently reduced.
Abnormally enlarged ER, which contains aggregated
type II collagen (Col2) and cartilage oligomeric matrix
protein (COMP), was observed in the proliferating
chondrocytes. These findings supported the model in
which CREB3L2 activates the Sec23a-dependent path-
way required for secretion of collagens and other extra-
cellular matrix proteins during normal chondrogenesis
[21]. This is in keeping with the role of CREB3L1 in
bone formation [18]. Together, the two studies pointed
to an essential role of CREB3L1 and CREB3L2 in pro-
tein secretion. This idea was further supported by two
recent studies conducted in other model organisms. In
one study, Xenopus CREB3L2 was shown to be required
for activation of the secretory pathway during notochord
formation [22]. In another more recent report, Droso-
phila dCREB-A as well as mammalian CREB3L1 and
CREB3L2 were found to be major and direct regulators
of secretory capacity [23].
CREB3L1 and CREB3L2 are more closely related to each
other than to CREB3, CREB3L3 and CREB3L4. The data
obtained from animal models raised two possibilities con-
cerning the role of CREB3 subfamily transcription factors
in the regulation of protein secretion. In one perspective,
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CREB3L1 and CREB3L2 might serve a specialized regula-
tory function in secretion, which is evolutionarily con-
served in dCREB-A, the single CREB3-like protein in
Drosophila [23]. In another model, all five members in the
CREB3 subfamily including CREB3, CREB3L3 and
CREB3L4 could be influential in the regulation of protein
secretion in other cell types. Further investigations are
required to clarify these two possibilities.
Consistent with a possible role of CREB3L3 in cell
secretion, Creb3l3-knockdown and Creb3l3-/- mice were
found to have a defect in the mobilization of acute
phase response upon ER stress [17]. CREB3L3 is highly
expressed during hepatogenesis. However, neither
Creb3l3-knockdown nor Creb3l3-/- mice showed defects
in liver formation [17]. In addition to acute phase
response genes such as the ones encoding C-reactive
protein and amyloid P-component, several other impor-
tant genes such as those of hepcidin, phosphoenolpyru-
vate carboxykinase and glucose 6 phosphatase were also
direct targets of CREB3L3 [24,25]. Thus, the physiologi-
cal function of CREB3L3 extends to iron homeostasis,
innate immunity and gluconeogenesis.
Knockout mouse models for Creb3l4 were created by
two independent groups. The Creb3l4-deficient mice
generated by one group had significantly reduced num-
ber of spermatozoa in the epididymis although their fer-
tility was not affected [26]. This observation might be
explained by increased apoptosis of meiotic or post-
meiotic germ cells [26]. This was also confirmed in the
Creb3l4-/- mice made by the other group [27]. Although
CREB3 is the prototype of the CREB3 subfamily, a
knockout mouse model for CREB3 has not been
reported. The physiological roles of CREB3 were
deduced primarily through overexpression studies con-
ducted in cultured cells and CREB3 interaction partners
identified from yeast two hybrid analyses. Particularly,
CREB3 was reported to interact with transcriptional
coactivator HCF1 [26], hepatitis C virus core protein
[28], CC chemokine receptor 1 [29] and dendritic cell
specific transmembrane protein [30]. Whether CREB3
indeed plays a role in chemokine signaling and dendritic
cell maturation in vivo awaits the creation of knockout
mice.
Physiological activators and targets of CREB3 subfamily
transcription factors
Phenotypic characterization of gene knockdown and
knockout mice has not only derived novel insights into
the physiological roles of the CREB3 subfamily of tran-
scription factors as detailed above, but also provided
important clues to their activators and targets. Particu-
larly, identification of their target genes in knockdown
and knockout mice by use of microarray technology
and other global approaches has substantially advanced
our understanding of this issue. Because some of these
activators and targets are cell type-specific, we should
take the expression pattern of CREB3 subfamily tran-
scription factors into consideration. Although all pro-
teins in this subfamily have similar domain
architecture, they exhibit quite different expression
profiles in different tissues: CREB3 is ubiquitous [2];
CREB3L1 is more abundantly expressed in some tis-
sues including pancreas, prostate and bone [18,31];
CREB3L2 can be detected in various tissues and the
strongest expression occurs in placenta, lung, spleen,
intestine and cartilage [4,21]; CREB3L3 has a liver spe-
cific expression [5,17,32]; and CREB3L4 is expressed in
different organs such as pancreas, liver, and gonads,
yet it is most abundant in prostate epithelial cells
[33,34]. Thus it is understandable that CREB3 subfam-
ily transcription factors might serve different physiolo-
gical roles in their target cells by modulating distinct
subsets of genes in response to specific stimuli.
Whether ER stress induces proteolytic activation of
CREB3 subfamily transcription factors remains contro-
versial. Earlier reports by independent groups suggested
that they are proteolytically activated by UPR induced by
pharmaceutical agents such as tunicamycin or thapsigar-
gin [17,18,21]. On the contrary, no activation of CREB3,
CREB3L3 and CREB3L4 was found upon ER stress in
several other reports. For example, proteolysis of CREB3
was not seen when UPR is activated [35,36]. The same
trend also applies to the proteolytic activation of
CREB3L3 and CREB3L4, which could not be induced by
tunicamycin or other ER stressors [33,37]. What would
be the direct inducer of the proteolytic activation of
CREB3 subfamily transcription factors if ER stress is not?
There are three schools of thoughts on this issue. First,
some membrane-associated bZIP proteins in plants can
be activated by salt stress or heat stress [38,39]. From an
evolutionary point of view, it will be of interest to see
whether mammalian transcription factors of the CREB3
subfamily might also be responsive to similar types of cel-
lular stress. Second, a prototypic membrane-bound tran-
scription factor known as sterol regulatory element
binding protein (SREBP) responds to intracellular con-
centration of cholesterol through an ER-anchored escort
protein named SREBP cleavage-activating protein
(SCAP) and its regulator Insig [40,41]. Further investiga-
tions are required to determine whether similar or dis-
tinct escort proteins might also be influential in the
activation of CREB3 subfamily transcription factors.
Third, the phenotypes of knockout mice and the targets
of CREB3 subfamily transcription factors found by global
analyses are most revealing in the identification of their
physiological activators. For instance, because CREB3L1
and CREB3L2 appear to be critical regulators of protein
secretion and are required for bone and cartilage
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formation [18,20-23], they are plausibly activated by phy-
siological inducers of extracellular matrix protein secre-
tion such as transforming growth factor b [42]. Likewise,
proteolysis of CREB3L3, which plays a role in acute
phase response, was found to be induced by interleukin
1b and interleukin 6 [17,43], proinflammatory cytokines
that regulate acute phase response. In line with its activa-
tion of genes involved in lipid metabolism [17], fatty
acids were found to be activators of CREB3L3 [44,45].
For CREB3L4, it was found that androgens could induce
its expression in a dose-dependent manner [6]. Consis-
tent with a role in dendritic cell maturation, CREB3 was
recently shown to be proteolytically activated after stimu-
lation with LPS [30]. Generally, physiological activators
of CREB3 subfamily transcription factors are more
diverse and not limited to ER stress alone.
CREB3 subfamily transcription factors are thought to
recognize cAMP-responsive element (CRE; TGACGTCA),
box-B element (TACACGTAATC), ER stress responsive
element II (ERSE-II; ATTGG-N-CCACG) and UPR ele-
ment (UPRE; TGACGTGG) [2,11,33,46,47]. Whether dif-
ferent factors prefer a particular enhancer element has not
been systematically investigated. Interestingly, microarray
analyses revealed that distinct subsets of target genes are
activated by CREB3L1, CREB3L2, CREB3L3 and CREB3L4
[17,18,20,21,23,33]. For example, CREB3L1 target genes
include collagen genes Col1a1 and Col1a2 as well as other
genes implicated in matrix protein production such as
Opn, Ocn, Papss2, Matn1 and Chst12 [18,20]. CREB3L2
activates Sec23a, Sec23b and Sec24c genes that are
involved in protein secretion [21], it could also turn on a
subset of innate immunity-related genes such as MxA
[23]. CREB3L3 stimulates Sap and Crp genes that are
important in acute phase response, as well as other genes
that may affect lipid metabolism [17]. Lastly, ANG, ANKH,
AQP9, ID2 and KDELR3 genes that are implicated in var-
ious cellular processes include protein sorting are regu-
lated by CREB3L4 [33]. Therefore, it will be of particularly
great interest to determine whether the different spectra
of target genes might be attributed to the cell type and/or
the recognition sequence. Because the enhancer sequence
recognized by CREB3 subfamily transcription factors has
only been characterized in a very limited number of target
genes, bioinformatic analysis and experimental validation
of the recognition sequence in additional target genes
should be performed to clarify whether these transcription
factors might recognize other elements. Although some of
these target genes might still be pertinent to ER stress and
UPR, many are directly involved in other biological pro-
cesses such as protein secretion, acute phase response,
innate immunity and lipid metabolism [17,18,20,21,23,33].
While elucidation of the link between ER stress and these
processes would expand our knowledge concerning the
biological function of UPR, full characterization of these
targets might derive novel insight into the physiological
roles of CREB3 subfamily transcription factors beyond ER
stress and UPR.
Roles of CREB3 subfamily transcription factors in cellular
transformation
CREB3 subfamily transcription factors exist ambiently
in an inactive form bound to the ER membrane. The
active form is usually short-lived and rapidly degraded
by the proteosome [32,37]. Plausibly, constitutive acti-
vation of these transcription factors might have dele-
terious effects that are either tumor suppressive or
oncogenic in different contexts. For example, whereas
the proapoptotic activity might suppress oncogenesis,
aberrant stimulation of extracellular matrix protein
secretion could promote tumor formation and metasta-
sis. It is therefore not surprising that all five members
of the CREB3 subfamily have been implicated in cellu-
lar transformation. Below we will briefly review the
roles of individual members in different types of
cancer.
CREB3 was known to be a binding partner of hepati-
tis C virus core protein. This interaction with the viral
oncoprotein might interfere with a tumor suppressive
function of CREB3 to promote cellular transformation
in hepatocellular carcinoma [28]. CREB3 was also
reported to be influential in the metastasis of breast
cancer cells [48]. CREB3L1 and CREB3L2 are fusion
partners of FUS in the generation of chimeric onco-
protein by chromosomal translocation in a soft tissue
sarcoma known as LGFMS [1,4,49,50]. The FUS-
CREB3L1 or FUS-CREB3L2 fusion oncoproteins
include the N-terminal fragment of FUS and the C-
terminal fragment of CREB3L1 or CREB3L2 harboring
the bZIP domain [4]. FUS-CREB3L2 has a very high
incidence of 96% in successfully evaluated LGFMS
cases whereas FUS-CREB3L1 was only found in one
exceptional case of LGFMS [49]. Since expression of
FUS-CREB3L2 is under the control of the strong FUS
promoter, FUS-CREB3L2 is generally thought to be
overexpressed in LGFMS. Additionally, the N-terminal
part of FUS also contributes transactivating and onco-
genic properties as in the case of other FUS-containing
fusion oncoproteins [51]. Thus, FUS-CREB3L2 is a
hyperactive transcription factor that turns on the
expression of various target genes. Consistent with a
role of CREB3L2 in stimulating the secretion of extra-
cellular matrix proteins [18,23], aberrant accumulation
of collagens was observed in LGFMS [52]. In this
regard, it will be of great interest to elucidate how
overproduction of collagen might underlie the pathol-
ogy of LGFMS. In further support of the oncogenic
property of CREB3L2, it was also found to be involved
in another chromosomal translocation in thyroid
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carcinoma that gives rise to the CREB3L2-PPARg
fusion oncogene [53]. The endocrine function of the
thyroid gland prompted us to the hypothesis that
CREB3L2-PPARg might also exert an impact on pro-
tein secretion in thyroid carcinoma. Further investiga-
tions are needed to test this hypothesis. Finally, a
recent RNAi screen revealed a role for CREB3L2 in
the survival pathway in malignant glioma cells. This
was mediated through ATF5 and an ATF5 target
known as myeloid cell leukemia sequence-1 (MCL1).
The transcription of ATF5 was activated by CREB3L2,
which was induced by Ras-mitogen-activated protein
kinase or phosphoinositide-3-kinase signaling pathway.
Taken together, these findings revealed an antiapopto-
tic activity of CREB3L2 and provided a new mechan-
ism to explain the uncontrolled proliferation of
malignant glioma cells [54]. CREB3L3 was found to be
underexpressed in hepatocellular carcinoma and to
serve a growth suppressive role in hepatocytes [32]. In
this regard, it will be intriguing to see whether the
Creb3l3-/- mice might be more susceptible to liver can-
cer. Finally, the higher abundance of CREB3L4 in pros-
tate cancer cells and its inducibility by androgens are
in line with a crucial role for CREB3L4 in prostate car-
cinogenesis [6,34]. Nevertheless, further elucidation of
the roles of discrete transcription factors in the CREB3
subfamily in cellular transformation might derive new
approaches for rational design of targeted anti-cancer
agents.
Conclusions
The CREB3 subfamily transcription factors are not only
involved in ER stress and UPR as previously envisaged,
but also play a crucial role in many other biological pro-
cesses including cell secretion, bone and cartilage forma-
tion as well as oncogenesis. Understanding the
physiological activators and targets of this subfamily by
use of a combination of global unbiased analyses, indivi-
dual gene approaches and animal models will derive
new knowledge in transcriptional regulation and new
strategies in the intervention of human diseases.
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